Holen Sie sich die Stockscreener-App
2.15
5.08%
-0.115
Handel nachbörslich:
2.20
0.05
+2.33%
Schlusskurs vom Vortag:
$2.265
Offen:
$2.39
24-Stunden-Volumen:
21,454
Relative Volume:
0.68
Marktkapitalisierung:
$1.42M
Einnahmen:
$17.59M
Nettoeinkommen (Verlust:
$-13.12M
KGV:
-0.00997
EPS:
-215.5494
Netto-Cashflow:
$-8.60M
1W Leistung:
-8.90%
1M Leistung:
-46.91%
6M Leistung:
-91.31%
1J Leistung:
-86.35%
1-Tages-Spanne:
$2.1262
$2.39
1-Wochen-Bereich:
$2.03
$2.40
52-Wochen-Spanne:
$1.95
$168.00
22nd Century Group, Inc. Stock (XXII) Company Profile
Firmenname
22nd Century Group, Inc.
Sektor
Branche
Telefon
716-270-1523
Adresse
8560 Main Street, Williamsville, NY
Compare XXII vs VRTX, REGN, ARGX, ALNY, INSM
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
XXII
22nd Century Group, Inc.
|
2.15 | 1.50M | 17.59M | -13.12M | -8.60M | -215.55 |
VRTX
Vertex Pharmaceuticals Inc
|
434.30 | 111.45B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
763.04 | 80.54B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
748.25 | 46.32B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
330.34 | 42.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
INSM
Insmed Inc
|
163.81 | 35.01B | 606.42M | -1.28B | -997.58M | -6.403 |
22nd Century Group, Inc. Stock (XXII) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2022-07-21 | Eingeleitet | Alliance Global Partners | Buy |
| 2022-06-15 | Eingeleitet | Craig Hallum | Buy |
| 2022-03-08 | Eingeleitet | ROTH Capital | Buy |
| 2021-07-23 | Eingeleitet | Cowen | Outperform |
| 2017-10-16 | Bestätigt | Chardan Capital Markets | Buy |
| 2016-08-11 | Bestätigt | Chardan Capital Markets | Buy |
Alle ansehen
22nd Century Group, Inc. Aktie (XXII) Neueste Nachrichten
Death Cross: Does 22nd Century Group Inc outperform in volatile marketsMarket Volume Summary & Technical Entry and Exit Alerts - baoquankhu1.vn
XXII PE Ratio & Valuation, Is XXII Overvalued - Intellectia AI
XXII Technical Analysis | Trend, Signals & Chart Patterns | 22ND CENTURY GROUP INC (NASDAQ:XXII) - ChartMill
XXII Should I Buy - Intellectia AI
22nd Century (XXII) registers $250M shelf; Needham ATM up to $1.84M - Stock Titan
Income Plays: Is ARDT stock a buy or sellTrade Signal Summary & Verified Swing Trading Watchlist - baoquankhu1.vn
Jobs Data: What are the future prospects of 22nd Century Group Inc2026 Buyback Activity & Daily Technical Forecast Reports - baoquankhu1.vn
Will 22nd Century Group Inc outperform tech stocksWeekly Stock Recap & Low Volatility Stock Suggestions - baoquankhu1.vn
22nd Century Group Achieves Debt-Free Status to Fuel Growth Strategy - AD HOC NEWS
XXII (22nd Century Group) Debt-to-EBITDA : -0.15 (As of Dec. 2025) - GuruFocus
Tag: EBITDA - Tobacco Reporter
22nd Century Group Inc (XXII) Q4 2025 Earnings Call Highlights: Strategic Shift Fuels Growth Amidst Challenges - gurufocus.com
22nd Century Group Reports Q4 and Full Year 2025 Results: VLN® Expansion, Higher Margins, and Debt-Free Growth - Minichart
22nd Century Group Inc (XXII) Q4 2025 Earnings Call Highlights: Strategic Shift Fuels Growth ... By GuruFocus - Investing.com Canada
22nd Century Group, Inc. 2025 Annual Report: VLN Reduced Nicotine Cigarettes, Risks, and Business Overview - Minichart
22nd Century Debt-Free in Announcing 2025 Results - Tobacco Reporter
22nd Century Group, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - MarketScreener
Earnings call transcript: 22nd Century Group’s Q4 2025 shows strategic shift - Investing.com Australia
XXII: Transitioned to growth in 2025, launching VLN products and strengthening financials - TradingView
XXII Reports Q4 Revenue Decline with Strategic Adjustments in Fo - GuruFocus
22nd Century Group (XXII) Reports Q4 Revenue Decline and Misses Estimates - GuruFocus
22nd Century Group reports Q4 revenue $3.5M, exits 2025 debt-free with $7.1M cash - TradingView
22nd Century (NASDAQ: XXII) 2025 revenue drops to $17.6M as mix shifts - Stock Titan
22nd Century Group reports $17.59M revenue and $(71.26) EPS; narrower net loss - TradingView
22nd Century Group Q4 losses narrow on market expansion, improved margins - TradingView
Going concern risk and VLN nicotine strategy at 22nd Century (NASDAQ: XXII) - Stock Titan
Debt-free after a reset, 22nd Century expands low-nicotine push - Stock Titan
22nd Century Group Inc (XXII) Q4 2025: Everything You Need To Kn - GuruFocus
XXII Q4'25 Earnings: EPS estimate is (2.10) USD - TradingView
22nd Century Group, Inc. Auditor Raises 'Going Concern' Doubt - marketscreener.com
22nd Century (XXII) files registration for 33.87M underlying shares from Series B deal - Stock Titan
22nd Century Group Inc expected to post a loss of $7.35 a shareEarnings Preview - TradingView
XXII Q4'25 Earnings: revenue estimate is 4.05M USD - TradingView
22nd Century Group to Announce Q4, FY25 Results March 26 - Tobacco Reporter
22nd Century Group to Announce Fourth Quarter and Full Year 2025 Results on March 26, 2026 - 富途牛牛
22nd Century's March 26 webcast will detail 2025 results, 2026 plans - Stock Titan
22nd Century Group, Inc. Announces Series B Preferred Stock and Warrant Offering Under S-3 Registration Statement - Minichart
22nd Century Announces Series B Preferred Stock Financing - TipRanks
22nd Century Group Launches Up to $20 Million Series B Preferred Offering With Warrants; $16 Million Initial Close - TradingView
22nd Century Group (NASDAQ: XXII) launches $20M Series B preferred and warrant financing - stocktitan.net
22nd Century (XXII) Share Price Forecast & Price Target - Investing.com UK
Aug Setups: Does 22nd Century Group Inc stock have upside surprise potential2026 WrapUp & Target Return Focused Stock Picks - baoquankhu1.vn
22nd Century Group, Inc.: Fundamental Analysis and Financial Ratings | | US90137F4000 - marketscreener.com
22nd Century Group, Inc. Financial Disclosures & SEC Filings - TradingView
Earnings Report: Is 22nd Century Group Inc stock risky to hold nowJuly 2025 PreEarnings & Technical Entry and Exit Tips - baoquankhu1.vn
Buyback Watch: Will 22nd Century Group Inc outperform tech stocks2025 Volatility Report & Safe Swing Trade Setup Alerts - baoquankhu1.vn
22nd Century Group developing 100mm very low nicotine cigarette - MSN
Aug Macro: Is 22nd Century Group Inc benefiting from interest rate changesMarket Sentiment Summary & AI Enhanced Trading Signals - baoquankhu1.vn
22nd Century Positions VLN® Cigarettes for Growth as FDA Considers 0.7 mg/g Nicotine Cap - 2Firsts
22nd Century Group Pivots to Proprietary VLN Products Amid Nasdaq Compliance Efforts () - aktiencheck.de
22nd Century (XXII) Gains Momentum with VLN Low Nicotine Cigaret - GuruFocus
Finanzdaten der 22nd Century Group, Inc.-Aktie (XXII)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.87%
0.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):